Methods of preparing cytotoxic benzodiazepine derivatives

Patent metadata

Field	Value
Publication number	US-2018201626-A1
Application number	US-201715837832-A
Country	US
Kind code	A1
Filing date	Dec 11, 2017
Priority date	Jul 21, 2015
Publication date	Jul 19, 2018
Grant date	—

Abstract

The invention relates to novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.

First claim

1 - 18 . (canceled)

19 . A method of preparing a compound of formula (3A),

or a salt thereof, said method comprising the steps of:
(i) introducing an alcohol protecting group onto one of the primary alcohols of a compound of formula (1) by reacting the compound of formula (1A) with an alcohol protecting reagent,

to form a compound of formula (2A),

or a salt thereof; and
(ii) reacting a halogenating reagent, a sulfonating reagent or an esterification reagent with the compound of formula (2A),
wherein:
P 1 is an alcohol protecting group; and,
X 1 is a leaving group selected from the group consisting of: —Br, —I, —Cl, a sulfonate ester, and an activated ester (preferably, X 1 is —Br, —I, or a sulfonate ester).

20 . (canceled)

21 . The method of claim 19 , wherein the sulfonate ester represented by X 1 is mesylate, tosylate, brosylate, or triflate.

22 . The method of claim 21 , wherein the sulfonate ester represented by X 1 is mesylate.

23 . The method of claim 19 , wherein the method comprising reacting the compound of formula (2) with a sulfonating reagent in the presence of a non-nucleophilic base.

24 . The method of claim 23 , wherein the non-nucleophilic base is triethylamine, imidazole, diisopropylethylamine, pyridine, 2,6-lutidine, dimethylformamide, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), or tetramethylpiperidine.

25 . The method of claim 24 , wherein the non-nucleophilic base is triethylamine or diisopropylethylamine.

26 . The method of claim 23 , wherein the sulfonating reagent is methanesulfonic anhydride or methanesulfonyl chloride (MsCl).

27 . The method of claim 19 , wherein the method comprising reacting a halogenating reagent with the compound of formula (2A) and the halogenating reagent is methanesulfonyl chloride, thionyl chloride, bromine, hydrobromic acid, carbon tetrabromide, phosphorus tribromide, potassium bromide, hydroiodic acid, iodine, carbon tetraiodide, phosphorus triiodide, sodium iodide, or potassium iodide.

28 - 65 . (canceled)

66 . A method of preparing a compound of formula (IA),

or a pharmaceutically acceptable salt thereof, said method comprising the steps of:
(1) introducing an alcohol protecting group onto one of the primary alcohols of a compound of formula (1A),

to form a compound of formula (2A),

(2) reacting the compound of formula (2A) with a halogenating reagent, a sulfonating reagent or an esterification reagent to form a compound of formula (3A),

(3) reacting the compound of formula (3A) with a monomer compound of the formula (a 1 ),

to form a compound of formula (4A),

(4) reacting the compound of formula (4A) with an imine reducing agent to form a compound of formula (5A),

(5) reacting the compound of formula (5A) with an alcohol deprotecting reagent to form a compound of formula (6A),

(6) reacting the compound of formula (6A) with a second halogenating reagent, a second sulfonating reagent or a second esterification reagent to form a compound of formula (7A),

and
(7) reacting the compound of formula (7A) with a monomer compound of the formula (b1),

to form the compound of formula (IA); wherein:
P 1 is an alcohol protecting group; and,
X 1 and X 2 are each independently a leaving group selected from the group consisting of: —Br, —I, —Cl, a sulfonate ester and an activated ester.

67 - 93 . (canceled)

94 . A method of preparing a compound of formula (IA),

or a pharmaceutically acceptable salt thereof, said method comprising the steps of:
(1) introducing an alcohol protecting group onto one of the primary alcohols of the compound of formula (1A),

to form a compound of formula (2A),

(2) reacting a halogenating reagent, a sulfonating reagent or an esterification reagent with the compound of formula (2) to form a compound of formula (3A),

(3) reacting the compound of formula (3A) with a monomer compound of the formula (b1),

to form a compound of formula (8A),

(4) reacting the compound of formula (8A) with an alcohol deprotecting reagent to form a compound of formula (9A),

(5) reacting a second halogenating reagent, a second sulfonating reagent or a second esterification reagent with the compound of formula (9A) to form a compound of formula (10A),

(6) reacting the compound of formula (10A) with a monomer compound of the formula (d 1 )

to form a compound of formula (18A),

(7) when P 3 is an amine protecting group; reacting the compound of formula (18A) with an amine deprotecting reagent to form the compound of formula (IA), wherein:
P 3 is H or an amine protecting group;
P 1 is an alcohol protecting group; and
X 1 and X 2 are each independently a leaving group selected from the group consisting of: —Br, —I, —Cl, a sulfonate ester, and an activated ester.

95 . The method of claim 94 , wherein P 3 is H and the compound of (10A) is reacted with the monomer compound of (d 1 ) to form the compound of (IA).

96 - 309 . (canceled)

310 . The method of claim 19 , wherein the alcohol protecting group is a silyl prote

Assignees

• Immunogen Inc

Inventors

• Gérard Baudouin
• Shizuka Manami
• Miller Michael Louis
• Silva Richard A

Classifications

• A61P35/00

  Antineoplastic agents · CPC title

• C07C303/28 Primary

  by reaction of hydroxy compounds with sulfonic acids or derivatives thereof · CPC title

• C07D519/00 Primary

  Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title

• C07D487/04 Primary

  Ortho-condensed systems · CPC title

• C07K5/0804

  and aliphatic · CPC title